These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1187683)

  • 1. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chloro analog of vitamin K: antagonism of vitamin K action in normal and warfarin-resistant rats.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):775-9. PubMed ID: 4719463
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1 .
    Suttie JW
    Science; 1973 May; 180(4087):741-3. PubMed ID: 4702571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus).
    Markussen MD; Heiberg AC; Nielsen R; Leirs H
    Pest Manag Sci; 2003 Aug; 59(8):913-20. PubMed ID: 12916772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and destruction of prothrombin in the rat.
    Bell RG; Matschiner JT
    Arch Biochem Biophys; 1969 Dec; 135(1):152-9. PubMed ID: 5362918
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased susceptibility to the anticoagulant effect of warfarin in mice bearing the Lewis lung carcinoma. Role of vitamin K deficiency.
    Pezzi L; Gerna M; Roncaglioni MC; Vermeer C; Donati MB
    Biochem Pharmacol; 1986 Oct; 35(19):3239-42. PubMed ID: 3768019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylation.
    Cocchetto DM; Bjornsson TD
    Haemostasis; 1986; 16(5):321-36. PubMed ID: 3781349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K and oral anticoagulant drugs as competitive antagonists in man.
    O'Reilly RA
    Pharmacology; 1972; 7(3):149-58. PubMed ID: 5054585
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
    Walz DA; Kipfer RK; Olson RE
    J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal prothrombin in the vitamin K-deficient rat.
    Shah DV; Swanson JC; Suttie JW
    Thromb Res; 1984 Aug; 35(4):451-8. PubMed ID: 6484892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of vitamin K status in human subjects administered "minidose" warfarin.
    Bach AU; Anderson SA; Foley AL; Williams EC; Suttie JW
    Am J Clin Nutr; 1996 Dec; 64(6):894-902. PubMed ID: 8942414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin and the inhibition of vitamin K activity by an oxide metabolite.
    Bell RG; Matschiner JT
    Nature; 1972 May; 237(5349):32-3. PubMed ID: 4555434
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracellular distribution of vitamin K in the rat.
    Bell RG; Matschiner JT
    Biochim Biophys Acta; 1969 Sep; 184(3):597-603. PubMed ID: 5821023
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of prothrombin synthesis by K-vitamins compared in vitamin K-deficient and in brodifacoum-treated rats.
    Craciun AM; Groenen-van Dooren MM; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1998 Mar; 1380(1):75-81. PubMed ID: 9545541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces.
    Nakamura K; Toyohira H; Kariyazono H; Ishibashi M; Saigenji H; Shimokawa S; Taira A
    Artery; 1994; 21(3):148-60. PubMed ID: 7794122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.